Your browser doesn't support javascript.
loading
ABSTRACT
Nitric oxide (NO) is a biologic mediator of various physiologic functions. Recent evidence suggests the clinical utility of fractional exhaled NO (FeNO) as a biomarker for assessing asthma and other respiratory diseases. FeNO methodologies have been recently standardized by international research groups and subsequently validated in several Korean population studies. Normal ranges for FeNO have been reported for various ethnic groups, and the clinical utility has been widely evaluated in asthma and various respiratory diseases. Based on current evidence including most of Korean population data, this position paper aims to introduce the methodological considerations, and provide the guidance for the proper clinical application of FeNO measurements in Korean populations.
Asunto(s)
Palabras clave
Texto completo: 1 Banco de datos: WPRIM Asunto principal: Valores de Referencia / Asma / Etnicidad / Óxido Nítrico Tipo de estudio: Guideline Límite: Humans Idioma: En Año: 2015 Tipo del documento: Article
Texto completo: 1 Banco de datos: WPRIM Asunto principal: Valores de Referencia / Asma / Etnicidad / Óxido Nítrico Tipo de estudio: Guideline Límite: Humans Idioma: En Año: 2015 Tipo del documento: Article